Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 8,380 shares at $21.62 ($183K) on 2007-02-16, disclosed to the SEC on 2007-02-16.
Scheduled sale ($183k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.56 | 38 | $819 | 0.4% |
| 2 | $21.58 | 300 | $6K | 3.5% |
| 3 | $21.61 | 500 | $11K | 5.9% |
| 4 | $21.62 | 62 | $1K | 0.7% |
| 5 | $21.65 | 300 | $6K | 3.5% |
| 6 | $21.68 | 300 |
| $7K |
| 3.6% |
| 7 | $21.69 | 600 | $13K | 7.1% |
| 8 | $21.72 | 100 | $2K | 1.2% |
| 9 | $21.75 | 500 | $11K | 5.9% |
| 10 | $21.76 | 700 | $15K | 8.3% |
| 11 | $21.82 | 400 | $9K | 4.8% |
| 12 | $21.84 | 9 | $197 | 0.1% |
| 13 | $21.88 | 200 | $4K | 2.4% |
| 14 | $21.89 | 200 | $4K | 2.4% |
| 15 | $22.00 | 4,171 | $92K | 50.1% |
| Total | $21.86 avg | 8,380 | $183K | 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |